Brachytherapy

SCI SCIE

国际简称：BRACHYTHERAPY 参考译名：近距离放射治疗

主要研究方向：医学-核医学非预警期刊审稿周期：较慢,6-12周

《近距离放射治疗》(Brachytherapy)是一本由Elsevier Inc.出版的以医学-核医学为研究特色的国际期刊，发表该领域相关的原创研究文章、评论文章和综述文章，及时报道该领域相关理论、实践和应用学科的最新发现，旨在促进该学科领域科学信息的快速交流。该期刊是一本未开放期刊，近三年没有被列入预警名单。

3区中科院分区
Q3 JCR分区
101 年发文量
1.7 IF影响因子
未开放 是否OA
44 H-index
2002 创刊年份
Quarterly 出版周期
English 出版语言

Brachytherapy is an international and multidisciplinary journal that publishes original peer-reviewed articles and selected reviews on the techniques and clinical applications of interstitial and intracavitary radiation in the management of cancers. Laboratory and experimental research relevant to clinical practice is also included. Related disciplines include medical physics, medical oncology, and radiation oncology and radiology. Brachytherapy publishes technical advances, original articles, reviews, and point/counterpoint on controversial issues. Original articles that address any aspect of brachytherapy are invited. Letters to the Editor-in-Chief are encouraged.

[ 查看全部 ]

投稿咨询加急咨询

Brachytherapy期刊信息

ISSN：1538-4721
出版语言：English
是否OA：未开放
E-ISSN：1873-1449
出版地区：UNITED STATES
是否预警：否
出版商：Elsevier Inc.
出版周期：Quarterly
创刊时间：2002
开源占比：0.0471
Gold OA文章占比：10.49%
OA被引用占比：0.0233...
出版国人文章占比：0.04
出版撤稿占比：0
研究类文章占比：94.06%

Brachytherapy CiteScore评价数据（2026年6月最新版）

CiteScore

SJR

SNIP

CiteScore 指数

2.8

0.572

0.761

学科类别	分区	排名	百分位
大类：Medicine 小类：Radiology, Nuclear Medicine and Imaging	Q3	187 / 361	48%
大类：Medicine 小类：Oncology	Q3	267 / 428	37%

名词解释：CiteScore 是衡量期刊所发表文献的平均受引用次数，是在 Scopus 中衡量期刊影响力的另一个指标。当年CiteScore 的计算依据是期刊最近4年（含计算年度）的被引次数除以该期刊近四年发表的文献数。例如，2022年的 CiteScore 计算方法为：2022年的 CiteScore =2019-2022年收到的对2019-2022年发表的文件的引用数量÷2019-2022年发布的文献数量注：文献类型包括：文章、评论、会议论文、书籍章节和数据论文。

Brachytherapy中科院评价数据

《新锐期刊分区表》（2026年3月发布）

Top期刊	综述期刊	大类学科		小类学科
否	否	医学	3区	ONCOLOGY 肿瘤学 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING 核医学	4区 4区

Brachytherapy JCR评价数据

2025-2026年最新版

按JCI指标学科分区	收录子集	分区	排名	百分位
学科：ONCOLOGY	SCIE	Q4	273 / 333	18.2
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q3	137 / 217	37.1
学科：ONCOLOGY	SCIE	Q3	246 / 333	26.28
学科：RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING	SCIE	Q3	145 / 217	33.41

Brachytherapy历年数据统计

影响因子

中科院分区

Brachytherapy中国学者发文选摘

1、Ultrasound and CT-guided 125I implantation combined with TACE therapy in the treatment of recurrent HCC after RF
Author: Li, Ningjie; Yang, Ping; Fang, Jun; Li, Hongbo; Wan, Yulei; Wu, Xizi; Wang, Li

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 2, pp. 325-332. DOI: 10.1016/j.brachy.2025.11.001
2、Improved outcomes in primary hepatocellular carcinoma adjacent to large vessels: A combined approach of MRI-guided radiofrequency ablation and 125 I implantatio
Author: Miao, Xianhua; Guo, Rui; Lin, Qingfeng; Lin, Zhengyu

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 2, pp. 333-341. DOI: 10.1016/j.brachy.2025.12.005
3、AI-assisted 3D-printed transvaginal template guidance for interstitial brachytherapy in patients with cervical cancer with parametrial invasio
Author: Li, Huiling; Li, Xiuhua; Zhang, Jianqiu; Dai, Yitao; Lin, Huijuan; Xie, Xingyun; Yang, Meichun

Journal: BRACHYTHERAPY. 2026; Vol. 25, Issue 1, pp. 95-106. DOI: 10.1016/j.brachy.2025.10.011
4、Intraluminal brachytherapy using 125I seed strand combined with PTBD and Hepatic arterial infusion chemotherapy for unresectable Bismuth-Corlette III and IV stage hilar cholangiocarcinom
Author: Zhang, Zi-Han; Li, Min; Sun, Hui-Yi; Yang, Min-Jie; Yan, Zhi-Ping; Li, Fu-You; Liu, Ling-Xiao

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 3, pp. 431-438. DOI: 10.1016/j.brachy.2024.12.004
5、Quality control study of cervical cancer interstitial brachytherapy treatment plans using statistical process contro
Author: Chen, Xiao; Shi, Xiangxiang; Zhang, Huaiwen; Pang, Haowen

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 3, pp. 371-378. DOI: 10.1016/j.brachy.2024.12.007
6、Efficacy and safety of chemotherapy combined with iodine-125 seed brachytherapy for intermediate and advanced oncogenic driver gene-negative non-small cell lung cance
Author: Xia, Meng-hua; Liu, Kai-cai; Zhao, Wei; Cheng, Yi-zhuang; Shi, Liang-ping; Bi, Li-qin; Guo, Xue-ran; Zhang, Meng-xia; Lv, Wei-Fu

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. 92-102. DOI: 10.1016/j.brachy.2024.09.005
7、Deficits of proactive control in individuals with test anxiety: Evidence from ERP
Author: Wang, Lei; Zhou, Renlai

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. -. DOI: 10.1016/j.biopsycho.2025.108985
8、Establishment of an absolute measurement of the reference air kerma rate for HDR 192 Ir brachytherapy source
Author: Han, Jinpeng; Zhi, Shijie; Wang, Peiwei; Wang, Ji; Yang, Zhijun; Wang, Kun; An, Xingtao

Journal: BRACHYTHERAPY. 2025; Vol. 24, Issue 1, pp. 110-121. DOI: 10.1016/j.brachy.2024.09.006